Cargando…

Convallatoxin Promotes M2 Macrophage Polarization to Attenuate Atherosclerosis Through PPARγ-Integrin α(v)β(5) Signaling Pathway

INTRODUCTION: As the primary immune cells, macrophages play a key role in atherosclerotic progression. M2 macrophage polarization has been reported to promote tissue repair and attenuate plaque formation upon the expression of anti-inflammatory factors. Convallatoxin (CNT) is a natural cardiac glyco...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Yi, Shi, Xiujin, Han, Jialun, Peng, Wenxing, Fang, Zhenwei, Zhou, Yang, Xu, Xiaoyu, Lin, Jie, Xiao, Fucheng, Zhao, Limin, Lin, Yang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7914072/
https://www.ncbi.nlm.nih.gov/pubmed/33654384
http://dx.doi.org/10.2147/DDDT.S288728
_version_ 1783656950387441664
author Zhang, Yi
Shi, Xiujin
Han, Jialun
Peng, Wenxing
Fang, Zhenwei
Zhou, Yang
Xu, Xiaoyu
Lin, Jie
Xiao, Fucheng
Zhao, Limin
Lin, Yang
author_facet Zhang, Yi
Shi, Xiujin
Han, Jialun
Peng, Wenxing
Fang, Zhenwei
Zhou, Yang
Xu, Xiaoyu
Lin, Jie
Xiao, Fucheng
Zhao, Limin
Lin, Yang
author_sort Zhang, Yi
collection PubMed
description INTRODUCTION: As the primary immune cells, macrophages play a key role in atherosclerotic progression. M2 macrophage polarization has been reported to promote tissue repair and attenuate plaque formation upon the expression of anti-inflammatory factors. Convallatoxin (CNT) is a natural cardiac glycoside with anti-inflammatory pharmacological properties. However, whether CNT protects against atherosclerosis (AS) and underlying mechanisms is unknown. This work was designed to explore the potential effects of CNT on atherosclerosis. METHODS: In this study, Apolipoprotein E deficiency (ApoE(−/-)) mice fed with high-fat diet were established, and CNT (50 or 100 μg/kg) were intragastrically administrated for 12 weeks every day. In vitro, RAW264.7 macrophages stimulated with ox-LDL were treated with CNT (50 or 100 nM) for 24 h. The specific PPARγ antagonist, GW9662, was used to block the PPARγ signaling pathway in vitro. Then, the atherosclerotic lesions, macrophage polarization markers, inflammatory cytokines and PPARγ signaling pathway were examined in further examinations. RESULTS: Our results showed that the atherosclerotic lesions were reduced by CNT, as demonstrated by the downregulation of serum lipid level and aortic plaque area in AS mice. Furthermore, we found that CNT treatment promoted the expression of M2 macrophage markers (Arg1, Mrc1, Retnla and Chi3l3), and decreased the levels of pro-inflammatory cytokines (IL-6 and TNF-α), accompanied by the increase of anti-inflammatory factor (IL-10) in aortic vessels of AS mice. In ox-LDL-induced RAW264.7 cells, CNT administration also facilitated macrophages polarizing towards M2 subtype and inhibited inflammatory responses. Furthermore, both the in vivo and in vitro experiments showed CNT could increase the expression of PPARγ, Integrin α(v) and Integrin β(5), and GW9662 could block CNT-induced M2 macrophage polarization. CONCLUSION: Taken together, these data suggest that CNT may promote M2 macrophage polarization to exert an anti-atherosclerotic effect, partially through activating PPARγ-Integrin α(v)β(5) signaling pathway.
format Online
Article
Text
id pubmed-7914072
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-79140722021-03-01 Convallatoxin Promotes M2 Macrophage Polarization to Attenuate Atherosclerosis Through PPARγ-Integrin α(v)β(5) Signaling Pathway Zhang, Yi Shi, Xiujin Han, Jialun Peng, Wenxing Fang, Zhenwei Zhou, Yang Xu, Xiaoyu Lin, Jie Xiao, Fucheng Zhao, Limin Lin, Yang Drug Des Devel Ther Original Research INTRODUCTION: As the primary immune cells, macrophages play a key role in atherosclerotic progression. M2 macrophage polarization has been reported to promote tissue repair and attenuate plaque formation upon the expression of anti-inflammatory factors. Convallatoxin (CNT) is a natural cardiac glycoside with anti-inflammatory pharmacological properties. However, whether CNT protects against atherosclerosis (AS) and underlying mechanisms is unknown. This work was designed to explore the potential effects of CNT on atherosclerosis. METHODS: In this study, Apolipoprotein E deficiency (ApoE(−/-)) mice fed with high-fat diet were established, and CNT (50 or 100 μg/kg) were intragastrically administrated for 12 weeks every day. In vitro, RAW264.7 macrophages stimulated with ox-LDL were treated with CNT (50 or 100 nM) for 24 h. The specific PPARγ antagonist, GW9662, was used to block the PPARγ signaling pathway in vitro. Then, the atherosclerotic lesions, macrophage polarization markers, inflammatory cytokines and PPARγ signaling pathway were examined in further examinations. RESULTS: Our results showed that the atherosclerotic lesions were reduced by CNT, as demonstrated by the downregulation of serum lipid level and aortic plaque area in AS mice. Furthermore, we found that CNT treatment promoted the expression of M2 macrophage markers (Arg1, Mrc1, Retnla and Chi3l3), and decreased the levels of pro-inflammatory cytokines (IL-6 and TNF-α), accompanied by the increase of anti-inflammatory factor (IL-10) in aortic vessels of AS mice. In ox-LDL-induced RAW264.7 cells, CNT administration also facilitated macrophages polarizing towards M2 subtype and inhibited inflammatory responses. Furthermore, both the in vivo and in vitro experiments showed CNT could increase the expression of PPARγ, Integrin α(v) and Integrin β(5), and GW9662 could block CNT-induced M2 macrophage polarization. CONCLUSION: Taken together, these data suggest that CNT may promote M2 macrophage polarization to exert an anti-atherosclerotic effect, partially through activating PPARγ-Integrin α(v)β(5) signaling pathway. Dove 2021-02-23 /pmc/articles/PMC7914072/ /pubmed/33654384 http://dx.doi.org/10.2147/DDDT.S288728 Text en © 2021 Zhang et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Zhang, Yi
Shi, Xiujin
Han, Jialun
Peng, Wenxing
Fang, Zhenwei
Zhou, Yang
Xu, Xiaoyu
Lin, Jie
Xiao, Fucheng
Zhao, Limin
Lin, Yang
Convallatoxin Promotes M2 Macrophage Polarization to Attenuate Atherosclerosis Through PPARγ-Integrin α(v)β(5) Signaling Pathway
title Convallatoxin Promotes M2 Macrophage Polarization to Attenuate Atherosclerosis Through PPARγ-Integrin α(v)β(5) Signaling Pathway
title_full Convallatoxin Promotes M2 Macrophage Polarization to Attenuate Atherosclerosis Through PPARγ-Integrin α(v)β(5) Signaling Pathway
title_fullStr Convallatoxin Promotes M2 Macrophage Polarization to Attenuate Atherosclerosis Through PPARγ-Integrin α(v)β(5) Signaling Pathway
title_full_unstemmed Convallatoxin Promotes M2 Macrophage Polarization to Attenuate Atherosclerosis Through PPARγ-Integrin α(v)β(5) Signaling Pathway
title_short Convallatoxin Promotes M2 Macrophage Polarization to Attenuate Atherosclerosis Through PPARγ-Integrin α(v)β(5) Signaling Pathway
title_sort convallatoxin promotes m2 macrophage polarization to attenuate atherosclerosis through pparγ-integrin α(v)β(5) signaling pathway
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7914072/
https://www.ncbi.nlm.nih.gov/pubmed/33654384
http://dx.doi.org/10.2147/DDDT.S288728
work_keys_str_mv AT zhangyi convallatoxinpromotesm2macrophagepolarizationtoattenuateatherosclerosisthroughppargintegrinavb5signalingpathway
AT shixiujin convallatoxinpromotesm2macrophagepolarizationtoattenuateatherosclerosisthroughppargintegrinavb5signalingpathway
AT hanjialun convallatoxinpromotesm2macrophagepolarizationtoattenuateatherosclerosisthroughppargintegrinavb5signalingpathway
AT pengwenxing convallatoxinpromotesm2macrophagepolarizationtoattenuateatherosclerosisthroughppargintegrinavb5signalingpathway
AT fangzhenwei convallatoxinpromotesm2macrophagepolarizationtoattenuateatherosclerosisthroughppargintegrinavb5signalingpathway
AT zhouyang convallatoxinpromotesm2macrophagepolarizationtoattenuateatherosclerosisthroughppargintegrinavb5signalingpathway
AT xuxiaoyu convallatoxinpromotesm2macrophagepolarizationtoattenuateatherosclerosisthroughppargintegrinavb5signalingpathway
AT linjie convallatoxinpromotesm2macrophagepolarizationtoattenuateatherosclerosisthroughppargintegrinavb5signalingpathway
AT xiaofucheng convallatoxinpromotesm2macrophagepolarizationtoattenuateatherosclerosisthroughppargintegrinavb5signalingpathway
AT zhaolimin convallatoxinpromotesm2macrophagepolarizationtoattenuateatherosclerosisthroughppargintegrinavb5signalingpathway
AT linyang convallatoxinpromotesm2macrophagepolarizationtoattenuateatherosclerosisthroughppargintegrinavb5signalingpathway